Sign In
Buy FMS
$25.66
-0.0400 (-0.156%)
At Close: Jul 31, 2026
Fresenius Medical's (FMS) Q2 Earnings Miss, Revenues Top
02:29pm, Tuesday, 02'nd Aug 2022 Zacks Investment Research
Fresenius Medical's (FMS) second-quarter earnings benefit from strong performance across all the geographic regions and segments. However, rising costs hurt margins.
Fresenius Medical's (FMS) Q2 Earnings Miss, Revenues Top
12:05pm, Tuesday, 02'nd Aug 2022
Fresenius Medical's (FMS) second-quarter earnings benefit from strong performance across all the geographic regions and segments. However, rising costs hurt margins.
Fresenius Medical Care: Best Time In 21 Years To Buy This High-Yield Dividend Aristocrat
11:00am, Saturday, 30'th Jul 2022 Seeking Alpha
Fresenius isn't just an undervalued aristocrat, it's a company and stock that could present strong returns in the next five years.
Fresenius Medical Care: Best Time In 21 Years To Buy This High-Yield Dividend Aristocrat
07:00am, Saturday, 30'th Jul 2022
Fresenius isn't just an undervalued aristocrat, it's a Buffett-style anti-bubble "fat pitch" that could deliver 235% returns in the next five years. Even with the Pandemic-induced downturn, FMS is exp
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday
09:55am, Friday, 29'th Jul 2022 Benzinga
Gainers
Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11, 20
Why Shares of Solar Companies Are Trading Higher? 64 Stocks Moving In Thursday's Mid-Day Session
04:41pm, Thursday, 28'th Jul 2022 Benzinga
Gainers
Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) gained 231% to $2.63 on news that the company will be acquired By Henry Crown and Company for $3.25 per share. Petros Pharmaceuticals, however, con
Meta, Charter Communications, Southwest Airlines And Some Other Big Stocks Moving Lower On Thursday
03:45pm, Thursday, 28'th Jul 2022 Benzinga
Bausch Health Companies Inc. (NYSE: BHC) shares fell 50.3% to $4.3166 following reports of an order on a patent litigation over Xifaxan.
Pathward Financial, Inc. (NASDAQ: CASH) fell 25.2% to $32.26
Why Meta Platforms Is Trading Lower By More Than 6%: Here Are 34 Stocks Moving Premarket
10:09am, Thursday, 28'th Jul 2022 Benzinga
Gainers
JAKKS Pacific, Inc. (NASDAQ: JAKK) rose 34.7% to $23.01 in pre-market trading after the company reported better-than-expected Q2 results.
Athersys, Inc. (NASDAQ: ATHX) rose 35.1% to $0.2568 i
Fresenius now expects lower revenue, earnings in the second half, citing wage inflation and staff shortages in North America
08:13am, Thursday, 28'th Jul 2022
Shares of Fresenius Medical Care tumbled 13.7% in premarket trading on Thursday after telling investors to expect lower-than-expected revenue and net income in the second half of the year. The company
2 High-Yield Dividend Aristocrats Potentially Set To Soar And 10 You Should Ignore
01:15pm, Saturday, 23'rd Jul 2022 Seeking Alpha
Dividends are an essential part of achieving life-changing wealth in the stock market. Click here for 2 high-yield dividend aristocrats potentially set to soar.
11 High-Yield Dividend Aristocrats Perfect For The Coming Recession
01:15pm, Wednesday, 20'th Jul 2022 Seeking Alpha
In this article, I discuss about high-yield defensive dividend aristocrats that can help weather the recession. Click here to know them.
11 High-Yield Dividend Aristocrats Perfect For The Coming Recession
09:15am, Wednesday, 20'th Jul 2022
Fears of a recession are mounting, with BAC and Deutsche Bank now forecasting a mild downturn in 2023. A recession could even begin by December 2022. Even without a recession Morgan Stanley is confide
After Plunging 11.8% in 4 Weeks, Here's Why the Trend Might Reverse for Fresenius (FMS)
01:35pm, Tuesday, 19'th Jul 2022 Zacks Investment Research
The heavy selling pressure might have exhausted for Fresenius (FMS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts i
Here's Why You Should Retain Fresenius Medical (FMS) Stock Now
11:56am, Tuesday, 19'th Jul 2022 Zacks Investment Research
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
After Plunging 11.8% in 4 Weeks, Here's Why the Trend Might Reverse for Fresenius (FMS)
10:51am, Tuesday, 19'th Jul 2022
The heavy selling pressure might have exhausted for Fresenius (FMS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts i
